Abstract
Tablet splitting has been a practice widely used. The aim of this work is to investigate the influence of splitting on content uniformity of 25 mg captopril tablets, a common dosage form. Split tablets were obtained by using the hands, a knife or a tablet-splitter. Captopril reference product and two different brands codified as X and Y were used in this study. The method used for quantification was that described in The United States Pharmacopoeia, 30th ed. The results showed that the quality of the analyzed products was affected by splitting processes (by either using the hands, a knife or a tabletsplitter). Nevertheless, the use of tablet splitter produced halves more uniform than the other division processes considered. Moreover, similar products codified as X and Y had a greater discrepancy in content uniformity when knife was used to split the tablets, while splitting the tablets by hands produced the highest variation in the reference product. Considering that lack of information about the split tablets can result in an inadequate therapy, problems related to captopril tablet splitting could be minimized by the distribution of splitting devices.
Keywords: Captopril, content uniformity, pharmaceutical quality control, tablet splitting, tablet-splitter, High performance liquid chromatography
Current Pharmaceutical Analysis
Title:Evaluation of the Influence of Splitting on Content Uniformity of Captopril Tablets
Volume: 9 Issue: 2
Author(s): Fernanda de Lima Moreira, Elisa de Oliveira Silva, Rudy Bonfilio, Olimpia Maria Martins Santos and Magali Benjamim de Araujo
Affiliation:
Keywords: Captopril, content uniformity, pharmaceutical quality control, tablet splitting, tablet-splitter, High performance liquid chromatography
Abstract: Tablet splitting has been a practice widely used. The aim of this work is to investigate the influence of splitting on content uniformity of 25 mg captopril tablets, a common dosage form. Split tablets were obtained by using the hands, a knife or a tablet-splitter. Captopril reference product and two different brands codified as X and Y were used in this study. The method used for quantification was that described in The United States Pharmacopoeia, 30th ed. The results showed that the quality of the analyzed products was affected by splitting processes (by either using the hands, a knife or a tabletsplitter). Nevertheless, the use of tablet splitter produced halves more uniform than the other division processes considered. Moreover, similar products codified as X and Y had a greater discrepancy in content uniformity when knife was used to split the tablets, while splitting the tablets by hands produced the highest variation in the reference product. Considering that lack of information about the split tablets can result in an inadequate therapy, problems related to captopril tablet splitting could be minimized by the distribution of splitting devices.
Export Options
About this article
Cite this article as:
de Lima Moreira Fernanda, de Oliveira Silva Elisa, Bonfilio Rudy, Maria Martins Santos Olimpia and Benjamim de Araujo Magali, Evaluation of the Influence of Splitting on Content Uniformity of Captopril Tablets, Current Pharmaceutical Analysis 2013; 9 (2) . https://dx.doi.org/10.2174/1573412911309020003
DOI https://dx.doi.org/10.2174/1573412911309020003 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot Topic: Benefits, Problems and Alternatives to COX-2 Inhibition (Guest Editor: Angel Lanas)]
Current Topics in Medicinal Chemistry Synthesis, Characterization and Physico-chemical Properties of New 2-(4- Arylpiperazine-1-yl)-1-(3-methylbenzofuran-2-yl)ethanoles as Potential Antihypertensive Agents
Current Organic Chemistry Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?
Current Pharmaceutical Design Obesity and Oxidative Stress: Potential Roles of Melatonin as Antioxidant and Metabolic Regulator
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of TNFSF15 in the Modulation of Neovascularization and Inflammation
Current Hypertension Reviews The Use of the Dahl Rat to Understand the Genetics of Human Hypertension: 35 Years of Data
Current Hypertension Reviews Mn-SOD and Chronic Inflammation of Gastric Mucosa
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Disease Modification in Rheumatoid Arthritis and Osteoarthritis-Current and Emerging Targets and Therapeutics
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Protective Effect of Dietary Potassium against Cardiovascular Damage in Salt-Sensitive Hypertension: Possible Role of its Antioxidant Action
Current Vascular Pharmacology The Role of Nitric Oxide on Endothelial Function
Current Vascular Pharmacology Elevation of E-Selectin Concentrations may Correlate with Potential Endothelial Dysfunction in Individuals with Hypopituitarism During Therapy with Growth Hormone
Current Neurovascular Research Pulmonary Arterial Hypertension in Connective Tissue Diseases
Current Respiratory Medicine Reviews Obstructive Sleep Apnea and Stroke
Current Respiratory Medicine Reviews Elevated Heart Rate, A Risk Factor and Risk Marker of Cardiovascular Disease
Current Hypertension Reviews Hemodialysis Membranes for Acute and Chronic Renal Insufficiency
Current Neurovascular Research Comparison of Clinical Features at the Onset of Takayasu’s Arteritis According to Age and Sex
Current Vascular Pharmacology Current Strategies and Future Perspective for the Effective Treatment of Diabetic Retinopathy
Current Drug Therapy New Drugs, Therapeutic Strategies, and Future Direction for the Treatment of Pulmonary Arterial Hypertension
Current Medicinal Chemistry Engineering of Nanospheres Dispersed Microneedle System for Antihypertensive Action
Current Drug Delivery Risk for Cervical Intraepithelial Neoplasia in Systemic Lupus Erythematosus is not Related to Disease Severity
Current Rheumatology Reviews